MedTrace Logo

Caffeine Consumption and Cataract Prevention

NCT05194696 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2022-01-31

No results posted yet for this study

Summary

Effect of peroral caffeine consumption on the delay of cataract onset.

Conditions

  • Cataract

Interventions

BEHAVIORAL

Questionnaire

Patients have to answer a questionnaire about their caffeine consumption habits during lifetime

Sponsors & Collaborators

  • Vienna Institute for Research in Ocular Surgery

    lead OTHER

Principal Investigators

  • Oliver Findl, MD · Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2024-09-01
Completion
2025-09-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194696 on ClinicalTrials.gov